Salutary effect of disopyramide on left ventricular diastolic function in hypertrophic obstructive cardiomyopathy
Authors:
- Satoshi NakataniSNSatoshi Nakatani
- Seiki NagataSNSeiki Nagata
- Fuminobu IshikuraFIFuminobu Ishikura
- Yuichi KatagiriYKYuichi Katagiri
- Tohru OheTOTohru Ohe
- Kunio MiyatakeKMKunio Miyatake
Abstract
No abstract availableKeywords
This publication has 28 references indexed in Scilit:
- Acute dose-response effects of intravenous disopyramide in hypertrophic obstructive cardiomyopathyAmerican Heart Journal, 1993
- Effect of Disopyramide on Systolic and Early Diastolic Time Intervals in Patients with Hypertrophic CardiomyopathyThe Journal of Clinical Pharmacology, 1991
- Oral disopyramide therapy for obstructive hypertrophic cardiomyopathyThe American Journal of Cardiology, 1988
- An integrated mechanism for systolic anterior motion of the mitral valve in hypertrophic cardiomyopathy based on echocardiographic observationsAmerican Heart Journal, 1987
- Triple control of relaxation: implications in cardiac disease.Circulation, 1984
- Effects of disopyramide on left ventricular function: Assessment by radionuclide cineangiographyThe American Journal of Cardiology, 1983
- Muscular Subaortic StenosisNew England Journal of Medicine, 1982
- Verapamil: its potential for causing serious complications in patients with hypertrophic cardiomyopathy.Circulation, 1981
- Left ventricular relaxation and filling pattern in different forms of left ventricular hypertrophy: An echocardiographic studyThe American Journal of Cardiology, 1980
- Left ventricular compliance: Mechanisms and clinical implicationsThe American Journal of Cardiology, 1976